Related Experiment Video
Updated: May 24, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
New directions in fibromyalgia
Deanna Davenport1, Celso R Velázquez
1University of Missouri School of Medicine, Division of Immunology and Rheumatology, USA. davenportde@health.missouri.edu
Fibromyalgia is a complex condition characterized by widespread pain, fatigue, and sleep issues. Current diagnostic guidelines highlight numerous somatic symptoms, with new treatments offering improved management options.
Area of Science:
- Rheumatology
- Symptomatology
- Pharmacology
Background:
- Fibromyalgia is a prevalent disorder.
- It is characterized by chronic widespread pain, fatigue, and sleep disturbances.
- Differential diagnosis is broad, including rheumatic diseases and other conditions.
Purpose of the Study:
- To summarize current understanding of fibromyalgia.
- To highlight new diagnostic guidelines.
- To review available and emerging treatment options.
Main Methods:
- Review of current literature and diagnostic guidelines.
- Analysis of pharmacological and nonpharmacological treatment modalities.
- Inclusion of recently approved medications.
Main Results:
- New diagnostic guidelines emphasize the recognition of multiple somatic symptoms.
- Both pharmacological and nonpharmacological treatments are available.
- Three new medications have been recently approved for fibromyalgia treatment.
Conclusions:
- Fibromyalgia diagnosis requires consideration of diverse somatic symptoms.
- A multimodal approach to treatment is recommended.
- Recent medication approvals offer new therapeutic avenues for patients.
Related Concept Videos
Introduction to Fibroblasts
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

